Naltrexone is a generic equivalent of the drug naloxone which is officially recognized as an opioid receptor antagonist. Since the mid 1990s, the FDA has authorized the prescribed use of naltrexone hydrochloride to combat alcohol addiction in addition to opiate dependency. Low-dose naltrexone applies to a dosage less than the typical one for addiction treatment which ranges from 50.0 to 100.0 mg daily. Roughly a tenth of that quantity -- 4.5 mg or less daily -- is indicated in LDN. Since the published presentation of the first scientific human trials in 2007, LDN has garnered critical attention as potentially treating specific chronic and auto-immune health conditions. The alleviation of some multiple sclerosis symptoms, particularly, is generating considerable discussion.
Progressive loss of muscular coordination and uncontrollable spasmodic movements are familiar symptoms of MS. Evidence shows that LDN appears to exhibit analgesic and anti-inflammatory properties. Ironically, higher dosages of naltrexone don't. Reportedly, some MS patients have benefitted from the apparent contradiction. Most favorable is no cited occurrences of the gastrointestinal distress common to NSAIDS.
A low cost and the non-steroidal aspect of LDN adds to its attraction as an MS treatment. Customarily prepared in compound pharmacies, the drug may be prescribed in either capsule or liquid form. Due to its nonproprietary status, naltrexone is automatically birthed into a lesser price bracket.
The drug is swallowed once daily. Actual dosages may vary according to individual patient circumstances. Our pharmacists can advise on this.
Perhaps the most provocative characteristic of LDN is its apparent lack of attendant adverse reactions. Remarkably, the majority of LDN users haven't complained of side effects. Nor has any contraindication with other commonly prescribed drugs that may be included in one's daily regimen been expressed. Vivid dreams, including nightmares, account for the most documented side effect of LDN in a minority of cases.
"It is rare to find health professionals who are so willing to educate the patient on what they need to know."